These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7915367)

  • 1. Efficacy of low-density-lipoprotein lowering with statins.
    Seidel D; Cremer P
    Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915367
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of low-density-lipoprotein lowering with statins.
    Rosenson RS; Stein JH
    Lancet; 1994 Sep; 344(8923):683. PubMed ID: 7915366
    [No Abstract]   [Full Text] [Related]  

  • 3. Defined daily doses in relation to hypolipidaemic efficacy of lovastatin, pravastatin, and simvastatin.
    Illingworth DR; Erkelens DW; Keller U; Thompson GR; Tikkanen MJ
    Lancet; 1994 Jun; 343(8912):1554-5. PubMed ID: 7911877
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of low-density-lipoprotein lowering with statins.
    Leufkens HG; Herings RM; Urquhart J
    Lancet; 1994 Sep; 344(8923):683-4. PubMed ID: 7915368
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of low-density-lipoprotein lowering with statins.
    Marshall S; Meredith PA; Elliott HL
    Lancet; 1994 Sep; 344(8923):684. PubMed ID: 7915369
    [No Abstract]   [Full Text] [Related]  

  • 6. Consensus statement: Role of therapy with "statins" in patients with hypertriglyceridemia.
    Grundy SM
    Am J Cardiol; 1998 Feb; 81(4A):1B-6B. PubMed ID: 9526806
    [No Abstract]   [Full Text] [Related]  

  • 7. A 16-week fenofibrate treatment increases LDL particle size in type IIA dyslipidemic patients.
    Lemieux I; Laperrière L; Dzavik V; Tremblay G; Bourgeois J; Després JP
    Atherosclerosis; 2002 Jun; 162(2):363-71. PubMed ID: 11996956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous administration of HMG-CoA reductase inhibitors in hyperlipidaemic and normal rats.
    Joles J; Willekes-Koolschijn N; Koomans H; Van Tol A; Geelhoed-Mieras T; Crommelin D; Van Bloois L; Krajnc-Franken M; Cohen L; Griffioen M
    Lab Anim; 1992 Oct; 26(4):269-80. PubMed ID: 1447905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular pharmacology (VIII). The role of HMG CoA reductase inhibitors in the current treatment of hyperlipidemias].
    Carmena R
    Rev Esp Cardiol; 1995 Jan; 48(1):59-65. PubMed ID: 7878284
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of hydroxymethylglutaryl coenzyme A reductase inhibitors in patients with post-transplantation hyperlipemia].
    Martínez-Castelao A
    Med Clin (Barc); 1995 Nov; 105(18):719. PubMed ID: 8538262
    [No Abstract]   [Full Text] [Related]  

  • 11. [Which statin is more efficient? Concepts and applications in economic evaluation].
    García-Altés A; Jovell AJ
    Aten Primaria; 2000 Sep; 26(5):333-8. PubMed ID: 11100606
    [No Abstract]   [Full Text] [Related]  

  • 12. [Efficacy and safety of simvastatin in the treatment of hyperlipidemia in uremic patients undergoing hemodialysis treatment].
    Fiorini F; Patrone E; Ardu F; Castelluccio A
    Minerva Urol Nefrol; 1992; 44(2):165-8. PubMed ID: 1411867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statins and fibrates in the management of diabetic dyslipidemia.
    Durrington P
    Diabet Med; 1997 Jul; 14(7):513-6. PubMed ID: 9223386
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of simvastatin, an HMG-CoA reductase inhibitor, on plasma lipids and steroid hormones.
    Ide H; Fujiya S; Aanuma Y; Agishi Y
    Clin Ther; 1990; 12(5):410-20. PubMed ID: 2268863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing expenditures for statin-type lipid-lowering agents.
    Am J Health Syst Pharm; 1998 May; 55(10):995-6, 999. PubMed ID: 9606450
    [No Abstract]   [Full Text] [Related]  

  • 16. Lipid-lowering with statins and fibrinolytic parameters.
    Jovin IS; Heidinger K; Taborski U; Muller-Berghaus G
    Eur Heart J; 1997 Sep; 18(9):1516. PubMed ID: 9458463
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of three statins at lower maintenance doses.
    Carr-Lopez S; Exstrum T; Morse T; Shepherd M; Bush AC
    Clin Ther; 1999 Feb; 21(2):331-9. PubMed ID: 10211536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The rule of 5 and the rule of 7 in lipid-lowering by statin drugs.
    Roberts WC
    Am J Cardiol; 1997 Jul; 80(1):106-7. PubMed ID: 9205036
    [No Abstract]   [Full Text] [Related]  

  • 20. Effectiveness of high doses of simvastatin as monotherapy in mixed hyperlipidemia.
    Miller M; Dolinar C; Cromwell W; Otvos JD
    Am J Cardiol; 2001 Jan; 87(2):232-4, A9. PubMed ID: 11152850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.